The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 01, 2007
Filed:
Feb. 17, 2004
John Ellis, Saskatoon, CA;
Gordon Moore Allan, Belfast, GB;
Brian Meehan, Belfast, GB;
Edward Clark, Saskatoon, CA;
Deborah Haines, Saskatoon, CA;
Lori Hassard, Saskatoon, CA;
John Harding, Humboldt, CA;
Catherine Elisabeth Charreyre, Saint-Laurent de Mure, FR;
Gilles Emile Chappuis, Lyons, FR;
George Steve Krakowka, Colombus, OH (US);
Jean-christophe Francis Audonnet, Lyons, FR;
Francis Mcneilly, Newtonards, GB;
John Ellis, Saskatoon, CA;
Gordon Moore Allan, Belfast, GB;
Brian Meehan, Belfast, GB;
Edward Clark, Saskatoon, CA;
Deborah Haines, Saskatoon, CA;
Lori Hassard, Saskatoon, CA;
John Harding, Humboldt, CA;
Catherine Elisabeth Charreyre, Saint-Laurent de Mure, FR;
Gilles Emile Chappuis, Lyons, FR;
George Steve Krakowka, Colombus, OH (US);
Jean-Christophe Francis Audonnet, Lyons, FR;
Francis McNeilly, Newtonards, GB;
Merial SAS, Lyons, FR;
Abstract
Provided is a method for reducing viral load of porcine circovirus type 2 (PCV-2) in a pig by inducing an immune response against PCV-2 through the administration of an immunogenic composition comprising a PCV-2 antigen. A preferred antigen is a vector containing a PCV-2 nucleotide sequence. In a particularly preferred embodiment, the PCV-2 nucleotide sequence is ORF4, ORF13, or ORF4 and ORF13. In some embodiments, the immunogenic composition includes one or more additional pig pathogens.